346 related articles for article (PubMed ID: 29198152)
1. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
Chudiwal VS; Shahi S; Chudiwal S
Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
[TBL] [Abstract][Full Text] [Related]
2. Implementation of Quality by Design for Formulation of Rebamipide Gastro-retentive Tablet.
Ha JM; Seo JW; Kim SH; Kim JY; Park CW; Rhee YS; Park ES
AAPS PharmSciTech; 2017 Nov; 18(8):3129-3139. PubMed ID: 28526986
[TBL] [Abstract][Full Text] [Related]
3. Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride.
Nigusse B; Gebre-Mariam T; Belete A
PLoS One; 2021; 16(6):e0253391. PubMed ID: 34170952
[TBL] [Abstract][Full Text] [Related]
4. Risk based approach for design and optimization of stomach specific delivery of rifampicin.
Vora C; Patadia R; Mittal K; Mashru R
Int J Pharm; 2013 Oct; 455(1-2):169-81. PubMed ID: 23916823
[TBL] [Abstract][Full Text] [Related]
5. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
6. Quality by design (QbD) approach for design and development of drug-device combination products: a case study on flunisolide nasal spray.
Chudiwal SS; Dehghan MHG
Pharm Dev Technol; 2018 Dec; 23(10):1077-1087. PubMed ID: 27616074
[TBL] [Abstract][Full Text] [Related]
7. An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine.
Mishra SM; Rohera BD
Pharm Dev Technol; 2017 Nov; 22(7):889-903. PubMed ID: 27346282
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
Singh I; Saini V
Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
[TBL] [Abstract][Full Text] [Related]
9. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
11. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
[TBL] [Abstract][Full Text] [Related]
12. Gastroretentive Matrix Tablets of Boswellia Oleogum Resin: Preparation, Optimization, In Vitro Evaluation, and Cytoprotective Effect on Indomethacin-Induced Gastric Ulcer in Rabbits.
Yusif RM; Abu Hashim II; Mohamed EA; Badria FA
AAPS PharmSciTech; 2016 Apr; 17(2):328-38. PubMed ID: 26092303
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
14. Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach.
Gavan A; Porfire A; Marina C; Tomuta I
Acta Pharm; 2017 Mar; 67(1):53-70. PubMed ID: 28231048
[TBL] [Abstract][Full Text] [Related]
15. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
17. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
Patel A; Modasiya M; Shah D; Patel V
AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
[TBL] [Abstract][Full Text] [Related]
18. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
Rudraswamy-Math NR; Gupta VR
Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
[TBL] [Abstract][Full Text] [Related]
20. Development of Sustained Release System Based on High Water-Absorbable Gel Formation Using Croscarmellose Sodium, Alkaline Excipients and HPMC (ACSH SR System); Novel Application of Croscarmellose Sodium as a Gel Former.
Gomi M; Mizutani N; Senoo R; Matsubara N; Watanabe A; Maruyama M; Kimura G; Higaki K
Pharm Res; 2023 Dec; 40(12):3073-3086. PubMed ID: 37964084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
